Cancer induced anti-inflammation and its potentiation by tumor excision and rechallenge.
Tumor rechallenge following primary tumor excision elicits systemic anti-inflammation that occurs rapidly, affects granulocytes as well as macrophages and is more severe, longer in duration, and induced by fewer tumor cells than the macrophage specific anti-inflammatory effect sometimes seen after primary tumor challenge. Factors important in the pathogenesis of this abnormality are the following. First, primary tumor excision was required as defects did not occur when a second tumor was transplanted during primary tumor growth. Second, the abnormality was restricted to neoplastic cells since normal cells were unable to substitute for either primary or secondary tumor challenge. Third, the anti-inflammatory effect was not due to surgical trauma or local irritation. Fourth, defective inflammation occurred in syngeneic but not allogeneic rats, suggesting an immunological basis for the anti-inflammation. Fifth, elevated glucocorticoids, such as might be expected from an immunological reaction or release of IL-1, may be a contributing but not sole cause for the phenomenon.
D015127:9,10-Dimethyl-1,2-benzanthracene; D000818:Animals; D000951:Antigens, Neoplasm / Q000276:immunology; D003345:Corticosterone / Q000097:blood; D005354:Fibrosarcoma / Q000139:chemically induced / Q000276:immunology; D006098:Granulocytes / Q000276:immunology; D007249:Inflammation / Q000276:immunology*; D008264:Macrophages / Q000276:immunology; D008748:Methylcholanthrene; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000139:chemically induced / Q000276:immunology* / Q000601:surgery; D051381:Rats; D011917:Rats, Inbred Lew; D011919:Rats, Inbred Strains
D000951:Antigens, Neoplasm; D008748:Methylcholanthrene; D015127:9,10-Dimethyl-1,2-benzanthracene; D003345:Corticosterone